Literature DB >> 29082625

CHARGEd with neural crest defects.

Silke Pauli1, Ruchi Bajpai2, Annette Borchers3.   

Abstract

Neural crest cells are highly migratory pluripotent cells that give rise to diverse derivatives including cartilage, bone, smooth muscle, pigment, and endocrine cells as well as neurons and glia. Abnormalities in neural crest-derived tissues contribute to the etiology of CHARGE syndrome, a complex malformation disorder that encompasses clinical symptoms like coloboma, heart defects, atresia of the choanae, retarded growth and development, genital hypoplasia, ear anomalies, and deafness. Mutations in the chromodomain helicase DNA-binding protein 7 (CHD7) gene are causative of CHARGE syndrome and loss-of-function data in different model systems have firmly established a role of CHD7 in neural crest development. Here, we will summarize our current understanding of the function of CHD7 in neural crest development and discuss possible links of CHARGE syndrome to other developmental disorders.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  CHARGE syndrome; CHD7; chromatin remodeling; neural crest; neural crest development

Mesh:

Substances:

Year:  2017        PMID: 29082625     DOI: 10.1002/ajmg.c.31584

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  11 in total

1.  A unique case of CHARGE syndrome with craniosynostosis.

Authors:  Loizos Siakallis; Ai Peng Tan; Raouf Chorbachi; Kshitij Mankad
Journal:  Childs Nerv Syst       Date:  2018-11-29       Impact factor: 1.475

2.  Sema3E is required for migration of cranial neural crest cells in zebrafish: Implications for the pathogenesis of CHARGE syndrome.

Authors:  Zhi-Zhi Liu; Jingjing Guo; Yanli Lu; Wenfeng Liu; Xiaofeng Fu; Tianbing Yao; Yanjun Zhou; Hong A Xu
Journal:  Int J Exp Pathol       Date:  2019-08-28       Impact factor: 1.925

3.  CHD7 regulates cardiovascular development through ATP-dependent and -independent activities.

Authors:  Shun Yan; Rassarin Thienthanasit; Dongquan Chen; Erik Engelen; Joanna Brühl; David K Crossman; Robert Kesterson; Qin Wang; Karim Bouazoune; Kai Jiao
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-30       Impact factor: 11.205

Review 4.  Wnt Signaling in Neural Crest Ontogenesis and Oncogenesis.

Authors:  Yu Ji; Hongyan Hao; Kurt Reynolds; Moira McMahon; Chengji J Zhou
Journal:  Cells       Date:  2019-09-29       Impact factor: 6.600

Review 5.  CHARGE syndrome: genetic aspects and dental challenges, a review and case presentation.

Authors:  Manogari Chetty; Tina Sharon Roberts; Mona Elmubarak; Heidre Bezuidenhout; Liani Smit; Mike Urban
Journal:  Head Face Med       Date:  2020-05-08       Impact factor: 2.151

6.  The histone methyltransferase KMT2D, mutated in Kabuki syndrome patients, is required for neural crest cell formation and migration.

Authors:  Janina Schwenty-Lara; Denise Nehl; Annette Borchers
Journal:  Hum Mol Genet       Date:  2020-01-15       Impact factor: 6.150

Review 7.  Epigenetic Regulation of Cardiac Neural Crest Cells.

Authors:  Shun Yan; Jin Lu; Kai Jiao
Journal:  Front Cell Dev Biol       Date:  2021-04-21

Review 8.  Semaphorin Regulation by the Chromatin Remodeler CHD7: An Emerging Genetic Interaction Shaping Neural Cells and Neural Crest in Development and Cancer.

Authors:  Antonella Lettieri; Roberto Oleari; Alyssa J J Paganoni; Cristina Gervasini; Valentina Massa; Alessandro Fantin; Anna Cariboni
Journal:  Front Cell Dev Biol       Date:  2021-04-01

9.  Single-cell atlas of early chick development reveals gradual segregation of neural crest lineage from the neural plate border during neurulation.

Authors:  Ruth M Williams; Martyna Lukoseviciute; Tatjana Sauka-Spengler; Marianne E Bronner
Journal:  Elife       Date:  2022-01-28       Impact factor: 8.140

Review 10.  Congenital heart defects in CHARGE: The molecular role of CHD7 and effects on cardiac phenotype and clinical outcomes.

Authors:  Joshua K Meisner; Donna M Martin
Journal:  Am J Med Genet C Semin Med Genet       Date:  2019-12-13       Impact factor: 3.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.